The estimated Net Worth of Jon R Cohen is at least $8.91 million dollars as of 10 May 2021. Jon Cohen owns over 50,000 units of Opko Health Inc stock worth over $195,000 and over the last 15 years he sold OPK stock worth over $8,718,310. In addition, he makes $0 as Director et Executive Chairman of BioReference Laboratories at Opko Health Inc.
Sign up
Jon Cohen OPK stock SEC Form 4 insiders trading
Jon has made over 4 trades of the Opko Health Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of OPK stock worth $190,500 on 10 May 2021.
The largest trade he's ever made was exercising 160,029 units of Opko Health Inc stock on 14 November 2014 worth over $8,860,806. On average, Jon trades about 10,272 units every 61 days since 2010. As of 10 May 2021 he still owns at least 125,000 units of Opko Health Inc stock.
You can see the complete history of Jon Cohen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jon Cohen biography
Dr. Jon Roger Cohen serves as Director, Executive Chairman of BioReference Laboratories of the Company. Dr. Cohen previously served for nearly a decade as a senior executive at Quest Diagnostics Incorporated. Prior to his tenure at Quest Diagnostics, he served as Chief Policy Advisor for Governor David Paterson and for six years as Chief Medical Officer for Northwell Health. Dr. Cohen is a vascular surgeon, having completed his residency in surgery at New York Presbyterian Hospital/Weill Cornell Medical Center and vascular surgery fellowship at the Brigham and Women's Hospital at Harvard Medical School. He has published over 100 peer-reviewed professional articles.
How old is Jon Cohen?
Jon Cohen is 66, he's been the Director et Executive Chairman of BioReference Laboratories of Opko Health Inc since 2020. There are 10 older and 10 younger executives at Opko Health Inc. The oldest executive at Opko Health Inc is John Paganelli, 85, who is the Independent Director.
What's Jon Cohen's mailing address?
Jon's mailing address filed with the SEC is 4400, Biscayne Boulevard, Buena Vista, Miami, Miami-Dade County, Florida, 33137, United States.
Insiders trading at Opko Health Inc
Over the last 18 years, insiders at Opko Health Inc have traded over $862,245 worth of Opko Health Inc stock and bought 128,867,460 units worth $425,265,065 . The most active insiders traders include Phillip Md Et Al Frost Neva..., Phillip Md Et Al Frost Gamm... et Phillip Md Et Al Frost Gamm.... On average, Opko Health Inc executives and independent directors trade stock every 4 days with the average trade being worth of $142,696. The most recent stock trade was executed by Phillip Md Et Al Frost Gamm... on 23 May 2024, trading 100,000 units of OPK stock currently worth $127,000.
What does Opko Health Inc do?
opko health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. our diagnostics business includes bioreference laboratories, the nation's third largest clinical laboratory with a core genetic testing business and a 400 person sales and marketing team to drive growth and leverage new products, including the 4kscore® prostate cancer test and the claros® 1 in office immunoassay platform. our pharmaceutical business features rayaldee, an fda approved treatment for shpt in stage 3-4 ckd patients with vitamin d insufficiency (launched in november 2016), varubitm for chemotherapy induced nausea and vomiting (oral formulation launched by partner tesaro and iv formulation pending fda approval), opk88004, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity, in phase 2 clinical trials, among the new class of glp-1 glucagon receptor dual agonists, and opk88003, a selective androgen receptor modulator for benig
What does Opko Health Inc's logo look like?
Complete history of Jon Cohen stock trades at Opko Health Inc et Quest Diagnostics
Opko Health Inc executives and stock owners
Opko Health Inc executives and other stock owners filed with the SEC include:
-
Phillip Frost,
Chairman of the Board, Chief Executive Officer -
Jane Hsiao,
Vice Chairman of the Board, Chief Technical Officer -
Steven Rubin,
Executive Vice President - Administration, Director -
Adam E. Logal,
Sr. VP & CFO -
Dr. Phillip Frost Ph.D.,
Chairman & CEO -
Adam Logal,
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer -
Dr. Jane H. Hsiao M.B.A., MBA, Ph.D.,
Vice Chairman & Chief Technical Officer -
Steven D. Rubin Esq., J.D.,
Exec. VP of Admin. & Director -
Richard Pfenniger,
Independent Director -
John Paganelli,
Independent Director -
Richard Krasno,
Independent Director -
Richard Lerner,
Independent Director -
Robert Fishel,
Independent Director -
Alice Yu,
Independent Director -
Yvonne Briggs,
Investor Relations -
Anthony Japour,
Independent Director -
Geoff Monk,
President of BioReference Laboratories -
Tony Cruz,
Chief Executive Officer, Transition Therapeutics, Inc -
Charles Bishop,
Chief Executive Officer of OPKO Renal -
Jon Cohen,
Director, Executive Chairman of BioReference Laboratories -
Dr. David Okrongly Ph.D.,
Pres of OPKO Diagnostics -
Jane Pine Wood Esq., J.D.,
Chief Legal Officer of Bio-Reference Laboratories -
Dr. Akhtar Ashfaq,
Sr. VP of Clinical R&D and Medical Affairs -
James DeMarco,
Sr. VP of Pharmaceutical Sales -
Dr. Arie Gutman,
Pres of API -
Alexis Borisy,
Director -
Phillip Md Et Al Frost Gamm...,
CEO & Chairman -
Gary J. Nabel,
Chief Innovation Officer -
Phillip Md Et Al Frost Neva...,
CEO & Chairman -
Phillip Md Et Al Frost,
CEO & Chairman -
Roger Md Medel,
-
Prem A Lachman,
-
Gamma Investment Trust Frost,
10% owner -
Subbarao V Uppaluri,
Senior VP- CFO -
Thomas E Beier,
Director -
Robert A Baron,
Director -
Michael Reich,
Director -
David A Eichler,
Director -
Dmitry Kolosov,
Director -
Md Pascal J Goldschmidt,,
Director -
Elias A. Zerhouni,
Vice Chairman and President